Park, S. J., Rabinowits, G., Panella, T. J., Homsi, J., Ruiz, E. S., Ellison, D. M., Kelley, M. J., Saenger, Y. M., Zuniga, R., Zhu, C., McIntyre, D. A., Quek, R. G., Wang, J., Gillis, K., Pouliot, J., Khushalani, N. I. (2025). CemiplimAb-rwlc survivorship and epidemiology (CASE): Interim results from a prospective study of the safety and effectiveness of cemiplimab in patients with advanced cutaneous squamous cell carcinoma (CSCC) in a real-world setting.. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2025.43.16_suppl.9533